Perspectives on Outsourcing

September 1st 2019

CDMOs are adding facilities and services to their portfolios in anticipation of the biologics industry’s continued growth.

July 1st 2019

The increasing growth in the cell- and gene-therapy markets is inspiring CDMOs to expand their services in this emerging biologic drug arena.

May 1st 2019

FDA inspections can create uncertainty. Supervision of the contract manufacturer is crucial in ensuring compliance.

March 1st 2019

Single-use systems can be a cost savings for CMOs, and these savings can be passed on to clients and, ultimately, to patients.